Humacyte, Inc. - *W EXP 08/27/202 (HUMAW) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2021 to Q4 2025

Type / Class
Equity / *W EXP 08/27/202
Symbol
HUMAW on Nasdaq
Price per share
$0.10
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
537,803
Total reported value
$49,940
% of total 13F portfolios
0%
Share change
+107,825
Value change
+$9,455
Number of holders
8
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 31 Dec 2025, 8 institutional investors reported holding 537,803 shares of Humacyte, Inc. - *W EXP 08/27/202 (HUMAW).

Institutional Holders of Humacyte, Inc. - *W EXP 08/27/202 (HUMAW) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 537,803 $49,940 +$9,455 $0.09 8
2025 Q3 429,978 $113,278 -$2,216 $0.27 6
2025 Q2 429,441 $167,934 +$2,142 $0.40 6
2025 Q1 424,584 $156,721 -$24,194 $0.37 5
2024 Q4 442,498 $806,283 -$164,472 $1.82 5
2024 Q3 533,939 $958,009 -$590,063 $1.80 7
2024 Q2 900,997 $1,260,554 +$410,640 $1.39 10
2024 Q1 638,738 $384,268 -$22,697 $0.60 6
2023 Q4 799,708 $333,447 -$32,962 $0.42 9
2023 Q3 866,272 $573,337 -$23,026 $0.72 9
2023 Q2 912,816 $659,654 +$186,717 $0.73 8
2023 Q1 635,813 $380,908 -$89,468 $0.60 8
2022 Q4 924,854 $447,851 +$9,443 $0.39 10
2022 Q3 721,848 $808,000 -$187,249 $1.11 9
2022 Q2 916,189 $810,000 +$190,024 $0.88 9
2022 Q1 635,226 $1,226,000 -$531,795 $1.94 10
2021 Q4 911,686 $2,328,000 +$701,323 $2.28 15
2021 Q3 528,391 $1,544,000 +$1,544,000 $2.90 12